Članki

Žane Temova Rakuša, Albin Kristl and Robert Roškar
Stability of reduced and oxidized coenzyme Q10 in finished products
Antioxidants, 2021, Vol. 10, no. 3, str. 1 - 17
https://www.mdpi.com/2076-3921/10/3/360

Adi Sharabi-Nov ... [et al.]
Maternal serum inhibin-A augments the value of maternal serum PlGF and of sFlt-1/PlGF ratio in the prediction of preeclampsia and/or FGR near delivery a secondary analysis
Reproductive medicine, 2021, Vol. 2, iss. 1, str. 35-49
https://www.mdpi.com/2673-3897/2/1/5

Jasna Grželj ... [et al.]
Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasis
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, 2021, Vol. 138, str. 1-11
https://www.sciencedirect.com/science/article/pii/S0753332221002419

Žan Toplak ... [et al.]
3D pharmacophore-based discovery of novel Kv10.1 inhibitors with antiproliferative activity
Cancers [Elektronski vir], 2021, Vol. 13, iss. 6, str. 1-24
https://www.mdpi.com/2072-6694/13/6/1244

Darko Siuka,Teja Fabjan, Joško Osredkar
The COVID-19 pandemic, seasons and the vitamin D laboratory strategy
International journal of sciences : basic and applied research, 2021, Vol. 56, no. 2, str. 182-189
https://gssrr.org/index.php/JournalOfBasicAndApplied/article/view/12287/5930

Aljaž Prevolšek, Mitja Kos
Upravljanje javnih podob vodilnih farmacevtskih podjetij na spletnih družbenih omrežjih Management of leading pharmaceutical companies' online social network profiles
Farmacevtski vestnik : strokovno glasilo slovenske farmacije = pharmaceutical journal of Slovenia, 2021, Letn. 72, št. 1, str. 65-74

Urška Nabergoj Makovec, Igor Locatelli & Mitja Kos
Improved adherence with medicines use review service in Slovenia : a randomized controlled trial
BMC health services research, 2021, Vol. 21, str. 1-16
https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-021-06223-8

Panagiotis-Dimitrios Mingas ... [et al.]
The evolving role of microsampling in therapeutic drug monitoring of monoclonal antibodies in inflammatory diseases

Molecules, 2021, 26, 6, št. članka 1787, str. 1-20

Ana Dolšak ... [et al.]
Novel selective IDO1 inhibitors with isoxazolo[5,4-d]pyrimidin-4(5H)-one scaffold
Pharmaceuticals, 2021, 14, 3, št. članka 265
https://www.mdpi.com/1424-8247/14/3/265

Andrea Scarpino ... [et al.]
WIDOCK : a reactive docking protocol for virtual screening of covalent inhibitors
Journal of computer-aided molecular design, 2021, Vol. 35, str. 223-244